Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus
⚠️ Не удалось извлечь полный текст. Показано краткое содержание из RSS.
🧭 Извлечение: failed · trafilatura_none
· confidence 20%
· диагностика
Low confidence: extractor returned no usable article text.
Low confidence: extractor returned no usable article text.
Полный текст не извлёкся (failed). Краткое содержание:
Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? Cureus